U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that Kleenex tissue was originally designed to be a gas mask filter? It was developed at the beginning of World War I to replace cotton, which was then in short supply as a surgical dressing.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 548/266.8 - Cyano or -C(=X)-, wherein X is chalcogen, bonded directly to the triazole ring


Subclass of Class 548 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the triazole ring is bonded directly to
No. of patents: 128
Last issue date: 07/22/2008


1        
NumberTitleIssue Date
7402606Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss
Heterocycle substituted ketoamide derivatives of Formula (I), wherein the substitutes A, D, A and R are defined as in claim in, which are useful as cathepsin K inhibitors are described herein. The described invention also includes methods of making such heterocycle ...
07/22/2008
7135475Amide substituted xanthine derivatives
The present invention is a 1,3,8 substituted xanthine derivative of formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are as defined in the specificat...
11/14/2006
7125725Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration
A novel achiral biaryl-type compound and a circular dichroism(CD) color fixing agent are provided. Furthermore, a method for determining an absolute configuration of a chiral compound is carried out by introducing the above achiral biaryl-type compound into the chir...
10/24/2006
7045512Fungicidal phenoxyphenylhydrazine derivatives
A fungicidally active compound of the formula: a) wherein Q is —NY—NH—, —N═N—, or X is oxygen...
05/16/2006
7034161Process for producing a ribofuranose
A method of converting pure α-anomer or β/α-anomer mixtures of 1,2,3,5-tetra-O-acetyl-L-ribofuranose to methyl-1-(2,3,5-tri-O-acetyl-β-L-ribofuranosyl)-1,2,4-triazole-3-carboxylate an intermediate for levovirin, as well as, the novel pure α-anomer, alpha 1,2,3,...
04/25/2006
6974801Inhibitors and methods of use thereof
New triterpenoid derivatives with various substituents at the C-17 position of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) were synthesized. Among them, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile (CNDDO), 1-(2-cyano-3,12-dioxooleana-1,9(11)-dien-...
12/13/2005
6933390Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
The invention concerns a process for the preparation of N-aryl-aza-heterocycles of the general formula I by reaction of aza-heterocycles with activated aryl halides with use of caesium carbonate without addition of fur...
08/23/2005
6919363Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
This invention relates to compounds having the Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Het and R5-R8 are set in the specification. The invention also ...
07/19/2005
6849636Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
Triazole derivatives of structural formula I are selective inhibitors of the 11β-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dysli...
02/01/2005
6831177Processes for the preparation of substituted propenone derivatives
Industrial and commercial processes for the preparation of 2-acyl-5-benzylfuran derivatives, 1,2,4-triazole-3-carboxylic acid ester derivatives or propenone derivatives having an anti-HIV activity; and useful crystals of the derivatives. A deblocking: (III-2), (IV-1...
12/14/2004
6821964Modulators of chemokine receptor activity
Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumul...
11/23/2004
6774239Process for the preparation of N,N′-carbonyldiazoles and azolide salts
This invention relates to the preparation of N,N′-carbonyldiazoles in a particularly advantageous manner by reacting corresponding azolide salts with phosgene in an aromatic compound or an ether as solvent. The azolide salts are preferably prepared by a novel proc...
08/10/2004
6747047Insecticidal anthranilamides
This invention provides compounds of Formula (1), their N-oxides and agriculturally suitable salts wherein A, B, J, R1, R2, R3 and R4 and n are as defined in the disclosure. Also disclosed are methods for controlling arthr...
06/08/2004
6727098Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration
A novel achiral biaryl-type compound and a circular dichroism (CD) color fixing agent are provided. Furthermore, a method for determining an absolute configuration of a chiral compound is carried out by introducing the above achiral biaryl-type compound into the chi...
04/27/2004
6656910Serine protease inhibitors
The present invention relates to certain substituted oxadiazole, thiadiazoles and triazole peptoids which are useful as inhibitors of serine proteases. Compounds of the invention are useful for treating, for example, adult respiratory distress syndrome, s...
12/02/2003
6656911Serine protease inhibitors
The present invention relates to certain substituted oxadiazole, thiadiazoles and triazole peptoids which are useful as inhibitors of serine proteases. Compounds of the invention are useful for treating, for example, adult respiratory distress syndrome, s...
12/02/2003
6620812Sulfamoyl compounds and agricultural and horticultural fungicides
A sulfamoyl compound of the general formulae (1): ##STR1## wherein R1 and R2 are each independently C1-4 alkyl, or R1 and R2 together are C4-6 alkylene or C4-6 alkyleneoxy, Y ...
09/16/2003
6548525Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors
The present application describes nitrogen containing heteroaromatics with ortho-substituted P1's and derivatives thereof of formula I: ##STR1## or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is N or NH and D is substituted ortho ...
04/15/2003
6469036Peptidyl heterocyclic ketones useful as tryptase inhibitors
The present invention relates to a series of peptidyl heterocyclic ketones which are inflammatory cell serine protease inhibitors and their compositions and methods for the prevention and treatment of a variety of immunomediated inflammatory disorders. Mo...
10/22/2002
6465658Process for the preparation of N,N'-carbonyldiazoles and azolide salts
This invention relates to the preparation of N,N'-carbonyldiazoles in a particularly advantageous manner by reacting corresponding azolide salts with phosgene in an aromatic compound or an ether as solvent. The azolide salts are preferably prepared by a n...
10/15/2002
6451824Sulfonylaminocarboxylic acids
Compounds of formula (I) ##STR1## are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved....
09/17/2002
6436989Prodrugs of aspartyl protease inhibitors
The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solu...
08/20/2002
64371691-naphthol compound and method for preparing compound having acidic proton using the same
1. A 1-naphthol compound represented by formula (I) below: ##STR1## wherein A represents the moiety of a compound having an acidic proton the pKa of a corresponding protonated form (AH) of which is 0 to 14, R1 represents an aliphatic group, ary...
08/20/2002
6403564Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
A method for treating a patient having chronic hepatitis C infection to eradicate detectable HCV-RNA involving a combination therapy using a therapeutically effective amount of ribavirin derivative of formula I and a therapeutically effective amount of in...
06/11/2002
6281201Base-modified derivatives of 2',5'-oligoadenylate and antiviral uses thereof
Antiviral compounds have the formula ##STR1## wherein m is zero, 1, 2 or 3; n is from 1 to 8, preferably 1, 2 or 3; most preferably 1 or 2; R is independently selected from the group consisting of ##STR2## provided that all R may not be ##STR3## R
08/28/2001
6265352Substituted carbamoyl triazoles and their use as herbicides
Substituted carbamoyltriazoles of the formula I as defined in the specification and the agriculturally useful salts thereof, processes for their preparation and their use as herbicides....
07/24/2001
6159938Serine protease inhibitors comprising ଱-keto heterocycles
Provided are methods of inhibiting the activity of a serine protease using protease inhibitors that include an alpha-keto heterocycle in their structure. The methods are useful in the treatment of ischemic heart or treatment of symptoms associated with bl...
12/12/2000
6100238Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
The present invention relates to certain substituted oxadiazole nonpeptides, which are useful as inhibitors of human neutrophil elastase (HNE) for the treatment of HNE-mediated processes implicated in conditions such as adult respiratory distress syndrome...
08/08/2000
6080772Thiazole compounds and methods of modulating signal transduction
The present invention relates to thiazole containing compounds capable of inhibiting protein tyrosine phosphatase activity. The invention further relates to the use of such compounds to modulate or regulate signal transduction by inhibiting protein tyrosi...
06/27/2000
60639285-lipoxygenase inhibitors
Novel compounds having the ability to inhibit 5-lipoxygenase enzyme and having the following formula I: ##STR1## and the pharmaceutically acceptable salts thereof, wherein Ar1 is a heterocyclic moiety which is selected from imidazolyl, pyr...
05/16/2000
6013836Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
This invention relates to N'-substituted-N,N'-disubstitutedhydrazines of formula I ##STR1## wherein X and X' are independently O, S, or NR; A' and B' are independently substituted or unsubstituted aryl or aromatic heterocycle; wherein F is alkyl...
01/11/2000
6005046Polyisocyanates blocked with 3,5-dimethyl-1,2,4-triazole
This invention relates to polyisocyanates which are partially or completely blocked with 3,5-dimethyl-1,2,4-triazole, to heat curable, one-component coating compositions containing these blocked polyisocyanates and to the resulting coatings....
12/21/1999
6001811Serine protease inhibitors--N-substituted derivatives
The present invention relates to oxadiazole, thiadiazole, and triazole peptoids that are inhibitors of serine protease, specifically human neutrophil elastase; which proteases are useful in treatment of adult respiratory distress syndrome, septic shock, a...
12/14/1999
5998379Serine protease inhibitors-proline analogs
The present invention relates to certain substituted oxadiazole, thiadiazole, and triazole peptoids that are useful as inhibitors of serine proteases, in particular human neutrophil elastase. Serine protease inhibitors of the invention are useful in the t...
12/07/1999
5935973Heterocyclcarboxamide derivatives and their use as therapeutic agents
Compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof in which A is methylene or O; B is methylene or O; g is 0,1,2,3 or 4; R1 is an optional substituent; U is an alkylene chain optionally substituted by one or more...
08/10/1999
5922867Method and compositions for the synthesis of dioxolane nucleosides with ଲ configuration
The present invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. In particular, this invention relates to the stereoselective synthesis of the beta (cis) isomer by gl...
07/13/1999
5912355Chiral synthesis of tertiary alcohols with a hydrolase
Method of preparing an optically active compound of formula, wherein R and R1 are independently alkyl, alkenyl, alkynyl, alkoxy, alkoxyalkyl, cycloalkyl, aryl, aralkyl, a heterocyclic group or a C1 -C4 alkyl-heterocycle, e...
06/15/1999
5891852Serine protease inhibitors-cycloheptane derivatives
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of human neutrophil elastase (HNE) for the treatment of HNE-mediated processes implicated in conditions such as adult respira...
04/06/1999
5889106Polyisocyanates blocked with 3,5-dimethyl-1,2,4-triazole
This invention relates to polyisocyanates which are partially or completely blocked with 3,5-dimethyl-1,2,4-triazole, to heat curable, one-component coating compositions containing these blocked polyisocyanates and to the resulting coatings....
03/30/1999
58831065-lipoxygenase inhibitors
Novel compounds having the ability to inhibit 5-lipoxygenase enzyme and having the following formula I: ##STR1## and the pharmaceutically acceptable salts thereof, wherein Ar1 is a heterocyclic moiety which is selected from imidazolyl, pyr...
03/16/1999
1        
 
Sign InRegister
Username  
Password   
forgot password?